Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

240 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Endocrine disruptor regulation of microRNA expression in breast carcinoma cells.
Tilghman SL, Bratton MR, Segar HC, Martin EC, Rhodes LV, Li M, McLachlan JA, Wiese TE, Nephew KP, Burow ME. Tilghman SL, et al. Among authors: mclachlan ja. PLoS One. 2012;7(3):e32754. doi: 10.1371/journal.pone.0032754. Epub 2012 Mar 5. PLoS One. 2012. PMID: 22403704 Free PMC article.
Glyceollin, a novel regulator of mTOR/p70S6 in estrogen receptor positive breast cancer.
Bratton MR, Martin EC, Elliott S, Rhodes LV, Collins-Burow BM, McLachlan JA, Wiese TE, Boue SM, Burow ME. Bratton MR, et al. Among authors: mclachlan ja. J Steroid Biochem Mol Biol. 2015 Jun;150:17-23. doi: 10.1016/j.jsbmb.2014.12.014. Epub 2015 Mar 12. J Steroid Biochem Mol Biol. 2015. PMID: 25771071 Free PMC article.
Antiestrogenic glyceollins suppress human breast and ovarian carcinoma tumorigenesis.
Salvo VA, Boué SM, Fonseca JP, Elliott S, Corbitt C, Collins-Burow BM, Curiel TJ, Srivastav SK, Shih BY, Carter-Wientjes C, Wood CE, Erhardt PW, Beckman BS, McLachlan JA, Cleveland TE, Burow ME. Salvo VA, et al. Among authors: mclachlan ja. Clin Cancer Res. 2006 Dec 1;12(23):7159-64. doi: 10.1158/1078-0432.CCR-06-1426. Clin Cancer Res. 2006. PMID: 17145841
Proteomic analysis of tumor necrosis factor-alpha resistant human breast cancer cells reveals a MEK5/Erk5-mediated epithelial-mesenchymal transition phenotype.
Zhou C, Nitschke AM, Xiong W, Zhang Q, Tang Y, Bloch M, Elliott S, Zhu Y, Bazzone L, Yu D, Weldon CB, Schiff R, McLachlan JA, Beckman BS, Wiese TE, Nephew KP, Shan B, Burow ME, Wang G. Zhou C, et al. Among authors: mclachlan ja. Breast Cancer Res. 2008;10(6):R105. doi: 10.1186/bcr2210. Epub 2008 Dec 16. Breast Cancer Res. 2008. PMID: 19087274 Free PMC article.
240 results